Gene: FAM98C
Official Full Name: family with sequence similarity 98 member Cprovided by HGNC
Gene Summary: Predicted to be part of tRNA-splicing ligase complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23543 | FAM98C Knockout cell line (HeLa) | Human | FAM98C | 1:3~1:6 | Negative | Online Inquiry |
KO23544 | FAM98C Knockout cell line (HCT 116) | Human | FAM98C | 1:2~1:4 | Negative | Online Inquiry |
KO23545 | FAM98C Knockout cell line (HEK293) | Human | FAM98C | 1:3~1:6 | Negative | Online Inquiry |
KO23546 | FAM98C Knockout cell line (A549) | Human | FAM98C | 1:3~1:4 | Negative | Online Inquiry |
FAM98C Gene Knockout Cell Lines are a state-of-the-art biotechnological tool designed for in-depth research into the functions and implications of the FAM98C gene. These genetically modified cell lines have been specifically engineered to lack the expression of the FAM98C gene, allowing researchers to investigate the gene's role in various cellular processes such as cell proliferation, differentiation, and response to external stimuli.
The primary function of FAM98C Gene Knockout Cell Lines lies in their ability to elucidate the biological pathways and mechanisms regulated by the FAM98C gene. By observing the phenotypic differences between knockout and wild-type cells, researchers can gather crucial insights into gene function, potential compensatory mechanisms, and the downstream effects on cellular metabolism and signaling pathways. This product serves as an invaluable tool in basic research, drug development, and disease modeling, making it applicable in both academic and clinical settings.
In terms of scientific importance, the FAM98C gene has been linked to various biological processes and pathologies, including cancer and metabolic disorders. Utilizing these knockout lines can accelerate the discovery of novel therapeutic targets, thereby facilitating the development of innovative treatments. Furthermore, these cell lines are optimized for scalability and adaptability, making them suitable for high-throughput screening applications.
Compared to traditional methods of gene knockout, our FAM98C Gene Knockout Cell Lines offer several advantages. They ensure consistent and reproducible results, saving researchers significant time on validating genetic modifications and providing a ready-to-use resource that enhances experimental efficiency. Additionally, our cell lines come with comprehensive characterization data, ensuring users can confidently interpret their findings.
For researchers, clinicians, and pharmaceutical companies seeking to advance their understanding of the FAM98C gene's role in health and disease, these cell lines present a unique opportunity to innovate. The value of this product lies in its potential to change the landscape of gene function studies and therapeutic research.
Our company prides itself on its commitment to delivering high-quality biological products backed by robust scientific expertise and rigorous quality control. We strive to support the research community with tools that propel scientific discovery and clinical translation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.